SCHEMBL7064261

SCHEMBL7064261

O[C@@H]1[C@H](O)[C@@H](COC(F)(F)F)O[C@H]1n1cnc2c(NC3CCSCC3)ncnc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.68
ADORA1 P30542 5/20 0.68
ADORA3 P0DMS8 6/20 0.66
TSHR P16473 3/20 0.62
PMP22 Q01453 2/20 0.62
ADORA2B P29275 2/20 0.62
GAA P10253 1/20 0.62
HTT P42858 1/20 0.62
SIGMAR1 Q99720 1/20 0.62
SLC29A1 Q99808 1/20 0.62
RXFP1 Q9HBX9 1/20 0.62
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
TP53 P04637 1/20 0.62
NFKB1 P19838 1/20 0.62
HIF1A Q16665 1/20 0.62
TAS1R3 Q7RTX0 1/20 0.62
TAS1R1 Q7RTX1 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.61
TDP1 Q9NUW8 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7067588 0.90 ADORA1 (0.77) ADORA2AADORA1ADORA3PMP22ADORA2B
SCHEMBL7067593 0.90 ADORA1 (0.77) ADORA2AADORA1ADORA3PMP22ADORA2B
SCHEMBL6660699 0.88 ADORA3 (0.84) ADORA2AADORA1ADORA3TSHRPMP22
SCHEMBL6253593 0.87 ADORA2A (0.80) ADORA2AADORA1ADORA3TSHRPMP22
SCHEMBL7066024 0.87 ADORA1 (0.76) ADORA2AADORA1ADORA3ADORA2BSLC29A1
SCHEMBL7067551 0.87 ADORA1 (0.76) ADORA2AADORA1ADORA3ADORA2BSLC29A1
SCHEMBL7064488 0.84 ADORA3 (0.65) ADORA2AADORA1ADORA3ADORA2BTAS1R3
SCHEMBL7067829 0.82 ADORA1 (0.78) ADORA2AADORA1ADORA3PMP22ADORA2B
SCHEMBL7067836 0.82 ADORA1 (0.78) ADORA2AADORA1ADORA3PMP22ADORA2B
SCHEMBL7067579 0.82 ADORA3 (0.61) ADORA2AADORA1ADORA3ADORA2BTAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1027363-B1 ADENOSINE A1-RECEPTOR AGONISTS GLAXO GROUP LTD (GB) 2003-06-04 EP claimed
EP-1027363-A2 ADENOSINE A1-RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2000-08-16 EP claimed
WO-1999024450-A2 ADENSINE A1 RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 1999-05-20 WO claimed
US-6407076-B1 ANTIISCHEMIC, ANTILIPOLYTIC, ANTICONVULSANT AND HYPOTENSIVE AGENTS; CARDIOVASCULAR AND NERVOUS SYSTEM DISORDERS; ATHEROSCLEROSIS SMITHKLINE BEECHAM CORPORATION 2002-06-18 US disclosed
EP-1027363-A2 ADENOSINE A1-RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2000-08-16 EP disclosed
WO-1999024450-A2 ADENSINE A1 RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 1999-05-20 WO disclosed